Literature DB >> 15657609

CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia.

Susanne Kohl1, Balazs Varsanyi, Gesine Abadin Antunes, Britta Baumann, Carel B Hoyng, Herbert Jägle, Thomas Rosenberg, Ulrich Kellner, Birgit Lorenz, Roberto Salati, Bernhard Jurklies, Agnes Farkas, Sten Andreasson, Richard G Weleber, Samuel G Jacobson, Günther Rudolph, Claudio Castellan, Helene Dollfus, Eric Legius, Mario Anastasi, Pierre Bitoun, Dorit Lev, Paul A Sieving, Francis L Munier, Eberhart Zrenner, Lindsay T Sharpe, Frans P M Cremers, Bernd Wissinger.   

Abstract

Achromatopsia is a congenital, autosomal recessively inherited disorder characterized by a lack of color discrimination, low visual acuity (<0.2), photophobia, and nystagmus. Mutations in the genes for CNGA3, CNGB3, and GNAT2 have been associated with this disorder. Here, we analyzed the spectrum and prevalence of CNGB3 gene mutations in a cohort of 341 independent patients with achromatopsia. In 163 patients, CNGB3 mutations could be identified. A total of 105 achromats carried apparent homozygous mutations, 44 were compound (double) heterozygotes, and 14 patients had only a single mutant allele. The derived CNGB3 mutation spectrum comprises 28 different mutations including 12 nonsense mutations, eight insertions and/or deletions, five putative splice site mutations, and three missense mutations. Thus, the majority of mutations in the CNGB3 gene result in significantly altered and/or truncated polypeptides. Several mutations were found recurrently, in particular a 1 bp deletion, c.1148delC, which accounts for over 70% of all CNGB3 mutant alleles. In conclusion, mutations in the CNGB3 gene are responsible for approximately 50% of all patients with achromatopsia. This indicates that the CNGB3/ACHM3 locus on chromosome 8q21 is the major locus for achromatopsia in patients of European origin or descent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657609     DOI: 10.1038/sj.ejhg.5201269

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  99 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

Review 2.  [Achromatopsia].

Authors:  C M Poloschek; S Kohl
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

3.  Achromatopsia as a potential candidate for gene therapy.

Authors:  Ji-Jing Pang; John Alexander; Bo Lei; Wentao Deng; Keqing Zhang; Qiuhong Li; Bo Chang; William W Hauswirth
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 4.  AAV-mediated gene therapy in mouse models of recessive retinal degeneration.

Authors:  J-J Pang; L Lei; X Dai; W Shi; X Liu; A Dinculescu; J H McDowell
Journal:  Curr Mol Med       Date:  2012-03       Impact factor: 2.222

Review 5.  Gene replacement therapy for retinal CNG channelopathies.

Authors:  Christian Schön; Martin Biel; Stylianos Michalakis
Journal:  Mol Genet Genomics       Date:  2013-07-17       Impact factor: 3.291

Review 6.  Gene therapy and genome surgery in the retina.

Authors:  James E DiCarlo; Vinit B Mahajan; Stephen H Tsang
Journal:  J Clin Invest       Date:  2018-06-01       Impact factor: 14.808

7.  Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism.

Authors:  Xi-Qin Ding; Cynthia S Harry; Yumiko Umino; Alexander V Matveev; Steven J Fliesler; Robert B Barlow
Journal:  Hum Mol Genet       Date:  2009-09-17       Impact factor: 6.150

Review 8.  The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness.

Authors:  R Lane Brown; Timothy Strassmaier; James D Brady; Jeffrey W Karpen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 9.  Genomic approaches for the discovery of genes mutated in inherited retinal degeneration.

Authors:  Anna M Siemiatkowska; Rob W J Collin; Anneke I den Hollander; Frans P M Cremers
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

10.  Rod and rod-driven function in achromatopsia and blue cone monochromatism.

Authors:  Anne Moskowitz; Ronald M Hansen; James D Akula; Susan E Eklund; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.